EventsMOL2NET'17, Conference on Molecular, Biomed., Comput. & Network Science and Engineering, 3rd ed.
Published
This submission belongs to the session 05. NANOBIOMAT-03: Nanotechnology & Biomaterials Sci. Congress, Jackson & Fargo, USA, 2017 of the event MOL2NET'17, Conference on Molecular, Biomed., Comput. & Network Science and Engineering, 3rd ed.
Published date
07 Dec, 2017
Citation
Riccardo Concu, Maria Natalia Dias Soeiro Cordeiro, Nanodesk project: development of a web platform for the selection of the nanoparticles of interest for the plastic industry, in Proceedings of MOL2NET'17, Conference on Molecular, Biomed., Comput. & Network Science and Engineering, 3rd ed., 15 January–15 December 2017, MDPI: Basel, Switzerland, doi: 10.3390/mol2net-03-05064
Share
Email
Facebook
Twitter
LinkedIn

Nanodesk project: development of a web platform for the selection of the nanoparticles of interest for the plastic industry

image
1. REQUIMTE, Department of Chemistry and Biochemistry, Faculty of Sciences, University of Porto, Rua do Campo Alegre, 687, 4169-007 Porto, Portugal.
Abstract

Predict Nanoparticles (NP) toxicity is one of the biggest deal for both toxicologists and computational chemistries. The Nanodesk project is a SUDOE interreg project (Project Code: SOE1/P1/E0215) aimed at the development of an interactive and easy to use web-platform which will be help the plastic industry in the selection of the safer nanomaterials (NMs). The web-platform will implement a series of machine learning approaches which will be identify the safer NMs amongst a list selected by the industry and the scientific committee of the project. The project has started on July 2016 and will last for 36 month.

Keywords
Nanotechnology
Nanoparticles
Nanomaterials
Nanotoxicology
NanoQSAR
Computational Chemistry
Poster
RC_MOL2NET-2017.pdf
Application of Self-Organizing Maps generated from Molecular Descriptors of Flavonoid in the Chemotaxonomy of the Asteraceae Family
In silico evaluation of spiro-acrydine derivatives as potential inhibitors of the receptor of human epidermic growth factor (HER2)/ Epidermic Growth Factor receiver (EGFR)